SNX Form 4: Dennis Polk reports multiple trust stock sales at ~$158–$161

Q: How were the sold SNX shares held prior to sale?

The shares are reported as held indirectly by a trust , of which Dennis Polk is a trustee, per the Form 4.

Q: Who signed the Form 4 for Dennis Polk?

The form is signed by Cheryl Grant, attorney-in-fact on 10/07/2025.

Filing Impact

(Moderate)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

Dennis Polk, a director and officer of TD SYNNEX Corp. (SNX), reported multiple sales of common stock executed on 10/06/2025 under a Rule 10b5-1 trading plan. The filing lists discrete disposals of 24, 1,276, 1,500, and 200 shares at weighted average prices between $157.92 and $160.96, with corresponding beneficial ownership balances reported as 84,636, 83,360, 81,860, and 81,660 shares (held indirectly by a trust). The form also records a larger disposal line showing 31,987 shares sold. The reporting person states the sales were effectuated pursuant to a 10b5-1 plan adopted on 10/13/2024 on behalf of the Polk family trust, where he serves as trustee. The form is signed by an attorney-in-fact on 10/07/2025.

Positive

Transactions executed under a Rule 10b5-1 plan, which provides an affirmative defense against insider trading claims
Sales are disclosed with weighted-average price ranges and the filer offers to provide a price breakdown on request

Negative

Reported disposals total a material block (a separate line shows 31,987 shares sold) which reduces the trust's indirect stake
Beneficial ownership decreased across multiple tranches, with post-sale balances shown as low as 81,660 shares

Insights

Insider sales were executed under a pre-established 10b5-1 plan; trust-held shares decreased in several tranches.

The transactions show structured disposals on 10/06/2025 with reported prices ranging from $157.92 to $160.96, and reported beneficial ownership updated in each line. The filer identifies the shares as held indirectly by a trust, and the sales were made under a Rule 10b5-1 plan adopted on 10/13/2024.

Using a 10b5-1 plan is a common governance mechanism to separate trading decisions from insider knowledge, but the filings still show material disposals including a 31,987-share line. Investors may track subsequent Form 4 filings for additional trust dispositions or changes in beneficial ownership over the next few reporting periods.

Insider Trade Summary

Net Seller: 3,000 shares ($477,266)

Net Sell 5 txns

Insider POLK DENNIS

Role Hyve Solutions Executive

Sold 3,000 shs ($477K)

Type	Security	Shares	Price	Value
Sale	Common Stock	24	$157.92	$4K
Sale	Common Stock	1,276	$158.51	$202K
Sale	Common Stock	1,500	$159.35	$239K
Sale	Common Stock	200	$160.96	$32K
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 84,636 shares (Indirect, By Trust); Common Stock — 31,987 shares (Direct)

Footnotes (1)

These sales were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 13, 2024, on behalf of the Polk family trust of which the reporting person is a trustee. Represents the weighted average sales price for a number of transactions effected at prices ranging from $158.07 to $158.93. The reporting person has provided to the issuer, and undertakes to provide upon request to the SEC staff, or any security holder of the issuer, information regarding the number of shares sold at each separate price within the range. Represents the weighted average sales price for a number of transactions effected at prices ranging from $159.02 to $159.87. The reporting person has provided to the issuer, and undertakes to provide upon request to the SEC staff, or any security holder of the issuer, information regarding the number of shares sold at each separate price within the range.

Form 4 Insider Transactions: What Each Field Means →

10/07/2025 - 04:56 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

POLK DENNIS

(Last)

(First)

(Middle)

44201 NOBEL DRIVE

(Street)

FREMONT

94538

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
TD SYNNEX CORP [ SNX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Hyve Solutions Executive

3. Date of Earliest Transaction (Month/Day/Year)
10/06/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	10/06/2025		S⁽¹⁾		24	D	$157.92	84,636	I	By Trust
Common Stock	10/06/2025		S⁽¹⁾		1,276	D	$158.51⁽²⁾	83,360	I	By Trust
Common Stock	10/06/2025		S⁽¹⁾		1,500	D	$159.35⁽³⁾	81,860	I	By Trust
Common Stock	10/06/2025		S⁽¹⁾		200	D	$160.96	81,660	I	By Trust
Common Stock								31,987	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. These sales were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 13, 2024, on behalf of the Polk family trust of which the reporting person is a trustee.

2. Represents the weighted average sales price for a number of transactions effected at prices ranging from $158.07 to $158.93. The reporting person has provided to the issuer, and undertakes to provide upon request to the SEC staff, or any security holder of the issuer, information regarding the number of shares sold at each separate price within the range.

3. Represents the weighted average sales price for a number of transactions effected at prices ranging from $159.02 to $159.87. The reporting person has provided to the issuer, and undertakes to provide upon request to the SEC staff, or any security holder of the issuer, information regarding the number of shares sold at each separate price within the range.

	/s/ Cheryl Grant, attorney-in-fact	10/07/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What did Dennis Polk (SNX) report on Form 4 dated 10/06/2025?

The filing reports multiple sales of SNX common stock executed on 10/06/2025 under a Rule 10b5-1 plan, including disposals of 24, 1,276, 1,500, 200, and a separate line showing 31,987 shares.

Were the SNX sales tied to a trading plan?

Yes. The reporting person states the sales were effectuated pursuant to a Rule 10b5-1 trading plan adopted on 10/13/2024 for the Polk family trust.

How were the sold SNX shares held prior to sale?

The shares are reported as held indirectly by a trust, of which Dennis Polk is a trustee, per the Form 4.

What prices were reported for the SNX sales?

The listed weighted-average prices range from $157.92 to $160.96; two weighted-average ranges are noted at $158.51 and $159.35 with per-line price ranges disclosed in the explanation.

Who signed the Form 4 for Dennis Polk?

The form is signed by Cheryl Grant, attorney-in-fact on 10/07/2025.